Home Cart Sign in  
Chemical Structure| 2411440-41-8 Chemical Structure| 2411440-41-8

Structure of JR14a
CAS No.: 2411440-41-8

Chemical Structure| 2411440-41-8

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

JR14a is a novel potent and selective antagonist of human Complement C3a receptor.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of JR14a

CAS No. :2411440-41-8
Formula : C25H26Cl2N4O3S
M.W : 533.47
SMILES Code : C(C=1SC(C(N[C@@H](CCCNC(=N)N)C(O)=O)=O)=C(C)C1)(C2=CC=C(Cl)C=C2)C3=CC=C(Cl)C=C3
MDL No. :MFCD34471093
InChI Key :OHRIKWUZKGNQKQ-IBGZPJMESA-N
Pubchem ID :145996525

Safety of JR14a

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319
Precautionary Statements:P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313

Isoform Comparison

Biological Activity

Description
JR14a, a potent thiophene antagonist of the human complement C3a receptor, exhibits selectivity for the human C3a receptor over the C5a receptor and can mitigate C3aR-mediated inflammation [1].

In Vitro:

Cell Line
Concentration Treated Time Description References
CHO-K1 cells 53 nM 90 minutes Evaluation of JR14a's inhibitory effect on FSK-stimulated cAMP accumulation Int J Mol Sci. 2023 Jan 21;24(3):2135
MC3T3-E1 cells 200 nM 48 hours To evaluate the effect of JR14a on D-gal-induced senescence in MC3T3-E1 cells. Results showed that JR14a significantly reduced the expression of senescence markers (p16, p21, p53) induced by D-gal and decreased the proportion of late apoptotic cells. J Biol Chem. 2025 May;301(5):108500

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
Mice D-gal-induced aging mouse model Injection 2 mg/kg/d Once daily for 4 weeks To evaluate the effect of JR14a on D-gal-induced bone microarchitectural disruption and bone loss. Results showed that JR14a partially reversed D-gal-induced bone loss by increasing osteoblast numbers, decreasing osteoclast numbers, and improving bone microarchitecture. J Biol Chem. 2025 May;301(5):108500

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.87mL

0.37mL

0.19mL

9.37mL

1.87mL

0.94mL

18.75mL

3.75mL

1.87mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories